Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multiple-dose safety study of Ricacell conditioned medium for local microvascular insufficiency disorders
jRCTs031250275Active, not recruiting
- Start
- Aug 2025
- Countries
- 1
01
Overview
Open-label trial in alopecia areata, cutaneous aging and erectile dysfunction (ED) (3 cohorts). Primary endpoint: Safety of multiple dose injection of conditioned medium. Started Aug 2025; status: active, not recruiting.
02
Conditions
alopecia areatacutaneous agingerectile dysfunction (ED)
Beyond the preview
Go deeper on jRCTs031250275.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031250275.